CAROL BURT - Corporate Board Profile

RESMED INC

Filing Date	Source Excerpt
2017-09-25	Carol Burt has served as our director since November 2013. She is a member of our audit committee. The table below summarizes the compensation received by our non-employee directors and Dr. Peter Farrell for the fiscal year ended June 30, 2017: Carol Burt Fees earned or paid in cash: $65,000, Restricted stock units: $249,973, Total: $314,973.
2018-10-03	Carol Burt has served as our director since November 2013. She is chair of our audit committee. ... Ms. Burt's skills and experience, particularly her over 35 years of experience in executive management, operations, strategy, mergers and acquisitions, corporate finance, accounting, and investment banking in the health insurance, healthcare services and financial services industries, combined with her board experience, led the board to the conclusion that she should serve as a director.
2019-10-08	Carol Burt has served as ResMed’s director since November 2013, and is chair of its audit committee. ... Ms. Burt’s skills and experience, particularly her over 35 years of experience in executive management, operations, strategy, mergers and acquisitions, corporate finance, accounting, and investment banking in the health insurance, healthcare services and financial services industries, combined with her board experience, led the board to the conclusion that she should serve as a director.
2020-10-06	Carol Burt has served as ResMed’s director since November 2013, and is chair of its audit and compliance oversight committees. She is also a member of its nominating and governance committee. ... Ms. Burt’s skills and experience, particularly her over 35 years of experience in executive management, operations, strategy, mergers and acquisitions, corporate finance, accounting, and investment banking in the health insurance, healthcare services, and financial services industries, combined with her board experience, led the board to the conclusion that she should serve as a director.
2021-10-06	Carol Burt has served as ResMed’s director since November 2013, and is chair of its audit and compliance oversight committees. She is also a member of its nominating and governance committee. ... Ms. Burt, principal of Burt-Hilliard Investments, is a private investor with more than 35 years’ experience in corporate governance, operations, strategy, finance, mergers and acquisitions, and investment banking. ... Ms. Burt graduated magna cum laude, from the University of Houston, earning a Bachelor of Business Administration. ... Ms. Burt’s executive management and board experience in the health insurance, healthcare services, medical technology, and financial services industries led the board to the conclusion that she should serve as a director.
2022-10-05	Carol Burt has served as a ResMed director since November 2013, and is chair of the audit and compliance oversight committees. She is also a member of the nominating and governance committee. ... Fiscal year 2022 director compensation table ... Carol Burt $105,000 fees earned in cash, $249,975 option awards, total $354,975.
2023-10-05	Carol Burt has served as a ResMed director since November 2013 and is chair of the audit and compliance oversight committees. She is also a member of the nominating and governance committee. ... Ms. Burt’s extensive executive management and board leadership experience in the health insurance, healthcare services, medical technology and financial services industries led the board to the conclusion that she should serve as a director.
2024-10-03	Carol Burt \| 66 Independent Principal of Burt-Hilliard Investments and Senior Advisor and Member of the Operating Council for Consonance Capital Partners Director since: 2013 Committees: Audit (Chair), Compliance Oversight (Chair), Nominating and Governance